1009 related articles for article (PubMed ID: 29650952)
21. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
22. Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.
Yang Q; Parker CL; McCallen JD; Lai SK
J Control Release; 2015 Dec; 220(Pt B):715-26. PubMed ID: 26407672
[TBL] [Abstract][Full Text] [Related]
23. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
24. Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy.
Yang HW; Hua MY; Liu HL; Tsai RY; Chuang CK; Chu PC; Wu PY; Chang YH; Chuang HC; Yu KJ; Pang ST
ACS Nano; 2012 Feb; 6(2):1795-805. PubMed ID: 22248493
[TBL] [Abstract][Full Text] [Related]
25. Strategies for surface modification of gelatin-based nanoparticles.
Mahmoudi Saber M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110407. PubMed ID: 31400613
[TBL] [Abstract][Full Text] [Related]
26. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
[TBL] [Abstract][Full Text] [Related]
27. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead.
Akhter MH; Beg S; Tarique M; Malik A; Afaq S; Choudhry H; Hosawi S
Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129777. PubMed ID: 33130062
[TBL] [Abstract][Full Text] [Related]
28. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
29. Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery.
Yurkin ST; Wang Z
Nanomedicine (Lond); 2017 Aug; 12(16):2007-2019. PubMed ID: 28745122
[TBL] [Abstract][Full Text] [Related]
30. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
[TBL] [Abstract][Full Text] [Related]
31. Nanomedicine for Cystic Fibrosis.
Ong V; Mei V; Cao L; Lee K; Chung EJ
SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
Sultana S; Khan MR; Kumar M; Kumar S; Ali M
J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
[TBL] [Abstract][Full Text] [Related]
33. Heat shock proteins and cancer: How can nanomedicine be harnessed?
Sauvage F; Messaoudi S; Fattal E; Barratt G; Vergnaud-Gauduchon J
J Control Release; 2017 Feb; 248():133-143. PubMed ID: 28088573
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
35. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine.
Pearce AK; O'Reilly RK
Bioconjug Chem; 2019 Sep; 30(9):2300-2311. PubMed ID: 31441642
[TBL] [Abstract][Full Text] [Related]
36. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
37. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
38. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
Krishnamurthy S; Ke X; Yang YY
Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774
[TBL] [Abstract][Full Text] [Related]
39. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP
AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
[TBL] [Abstract][Full Text] [Related]
40. Clinical developments in nanotechnology for cancer therapy.
Heidel JD; Davis ME
Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
